Ризедронат Тева 35 мг

Država: Izrael

Jezik: ruski

Izvor: Ministry of Health

Aktivni sastojci:

RISEDRONIC ACID AS SODIUM 35 MG

Dostupno od:

ABIC MARKETING LTD

ATC koda:

M05BA07

Farmaceutski oblik:

TABLETS

Administracija rute:

PER OS

Proizveden od:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Terapijska grupa:

RISEDRONIC ACID

Terapijske indikacije:

Treatment of postmenopausal osteoporosis to reduce the risk of vertebral fractures. Treatment of established postmenopausal osteoporosis to reduce the risk of hip fractures. Prevention of osteoporosis in postmenopausal women with increased risk of osteoporosis. Treatment of osteoporosis in men at high risk of fracture.

Datum autorizacije:

2011-10-01